The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
SKIN · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
ELTX · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | SKIN | BMRN | ELTX | ADUS |
|---|---|---|---|---|
| Moat Score (0–100) | 57 (highest) | 57 (highest) | 57 (highest) | 57 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 50 | 91 | 60 | 100 (highest) |
| Pricing power | 84 | 99 (highest) | 70 | 48 |
| Returns on capital | — | 0 | — | 12 (highest) |
| Balance-sheet safety | 28 | 73 (highest) | 55 | 65 |
| Capital discipline | 67 (highest) | 24 | 44 | 60 |
| Price vs. high estimate | No price data | 483% above high estimate | No price data | 71% above high estimate (largest discount to high estimate) |
| Market cap | $100.5M | $11.4B | $54.1M | $2.1B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |